Search Results
Apr 28, 2026, 09:00 ET Lost Money on Upstart, Inc. (UPST)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
performing its risk-separation processes; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approval rates was overstated; (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results,
More news about: The Gross Law Firm
Apr 28, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA
ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel's regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical
More news about: The Gross Law Firm
Apr 28, 2026, 09:00 ET Lost Money on ODDITY Tech Ltd. (ODD)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and
More news about: The Gross Law Firm
Apr 28, 2026, 09:00 ET CWH DEADLINE: The Gross Law Firm Reminds Camping World Holdings, Inc. Investors of Upcoming Securities Class Action Deadline
optimize profit using "data analytics;" (ii) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, the Company would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; (iv) the
More news about: The Gross Law Firm
Apr 28, 2026, 09:00 ET BW Deadline Alert: The Gross Law Firm Reminds Babcock & Wilcox Enterprises, Inc. (BW) Investors of Securities Class Action Deadline on June 15, 2026
(ii) Applied Digital did not need the products and services that B&W would purportedly supply pursuant to the power generation LNTP and contract; (iii) the foregoing, at the very least, would raise questions about the parties' actual intent behind entering into the power generation LNTP and contract,
More news about: The Gross Law Firm
Apr 28, 2026, 09:00 ET GEMI Shareholder Alert: Gemini Space Station, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
platform; (ii) Gemini had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, Gemini's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that Gemini
More news about: The Gross Law Firm
Apr 28, 2026, 09:00 ET Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries. J Am Coll Cardiol. 2017;69(11):1427–50.iii Cook S, Walker A, Hügli O, Togni M, Meier B. Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based
More news about: Abbott
Apr 28, 2026, 08:38 ET World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
delivers a toxin with high purity and high specific activity.In a pivotal randomized, double-blind, placebo- and active-controlled multicenter Phase III clinical trial conducted in China, Retoxin® met all primary and secondary endpoints. The study demonstrated superior efficacy, favorable safety
More news about: Claruvis Pharmaceutical
Apr 28, 2026, 08:38 ET World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
delivers a toxin with high purity and high specific activity.In a pivotal randomized, double-blind, placebo- and active-controlled multicenter Phase III clinical trial conducted in China, Retoxin® met all primary and secondary endpoints. The study demonstrated superior efficacy, favorable safety
More news about: Claruvis Pharmaceutical
Apr 28, 2026, 08:35 ET Letter from Barry Diller to IAC Shareholders: IAC Announces Name Change to People Incorporated
policies, economics or features (including those implemented by Google), as well as the potential expiration or modification of key commercial agreements, (iii) our ability to effectively market our products and services in a cost-efficient manner across evolving digital channels, (iv) our dependence on advertising
More news about: IAC
Apr 28, 2026, 08:30 ET HUHUTECH International Group Inc. Announces Fiscal Year 2025 Financial Results
contributed by (i) an approximately $18.6 million increase in share-based compensation, (ii) an approximately $1.3 million increase in impairment losses, (iii) a decrease of consulting and audit fees approximately $1.6 million.Research and development expenses were $0.9
More news about: HUHUTECH International Group Inc.
Apr 28, 2026, 07:27 ET Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
non-immunosuppressive oral, more accessible therapy earlier in the treatment pathway."MAVERIC Phase III TrialMAVERIC is a randomized, double-blind, placebo-controlled pivotal Phase III trial evaluating CardiolRx™ for the prevention of disease recurrence in patients with recurrent
More news about: Cardiol Therapeutics Inc.
Apr 28, 2026, 07:10 ET Amber International Holding Limited Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
from continuing operations represents net income/(loss) from continuing operations before (i) depreciation and amortization, (ii) finance income, net, (iii) income tax credit, (iv) share-based compensation, (v) other gains, net, (vi) unrealized loss in fair value of digital assets, and (vii) cost related
More news about: Amber International Holding Limited
Apr 28, 2026, 07:02 ET Zentiva odwołuje się od decyzji TSUE w sprawie Dyrektywy dotyczącej oczyszczania ścieków komunalnych
i inne przedsiębiorstwa w marcu 2025. W ramach skargi o stwierdzenie nieważności, Zentiva kwestionuje przepisy art. 9 i 10 w związku z Załącznikiem III do Dyrektywy UWWTD, która ustanawia rozszerzoną odpowiedzialność producenta (ROP) polegającą na obowiązku pokrycia co najmniej 80% kosztów tzw. oczyszczania
More news about: Zentiva Group a.s.
Apr 28, 2026, 07:02 ET Shutterstock Reports First Quarter 2026 Financial Results
performance and overall liquidity; (ii) facilitate management's internal comparisons of the historical operating performance of its business operations; (iii) facilitate management's external comparisons of the results of its overall business to the historical operating performance of other companies that
More news about: Shutterstock, Inc.
Apr 28, 2026, 07:00 ET BANKFIRST CAPITAL CORPORATION Reports First Quarter 2026 Earnings of $8.39 Million
"Basel III Rules," apply to both depository institutions and (subject to certain exceptions not applicable to the Company) their holding companies. The Basel III Rules also establish a "capital conservation buffer" of 2.5% above the regulatory minimum risk-based capital requirements. The Basel III minimum
More news about: BankFirst Capital Corporation
Apr 28, 2026, 07:00 ET Opera Reports First Quarter 2026 Results With Both Revenue and Adjusted EBITDA Exceeding High End of Guidance Ranges
defined as net income adjusted to exclude (i) profit (loss) from discontinued operations, (ii) gain (loss) on investments in unconsolidated entities, (iii) non-recurring expenses, (iv) impairment of non-financial assets, (v) amortization of acquired intangible assets, (vi) share-based compensation expenses,
More news about: Opera Limited
Apr 28, 2026, 07:00 ET Galaxy Announces First Quarter 2026 Financial Results
CoreWeave Leases (Phases I+II+III)
More news about: Galaxy Digital Inc.
Apr 28, 2026, 07:00 ET Honeywell Announces Board of Directors for Honeywell Aerospace
conditions related thereto; (ii) the possibility that the spin-off transaction will not be completed within the anticipated time period or at all; (iii) the possibility that the spin-off transaction will not achieve its intended benefits; (iv) the impact of the spin-off transaction on Honeywell's and Honeywell
More news about: Honeywell
Apr 28, 2026, 07:00 ET Stepan Reports First Quarter 2026 Results
Table III
More news about: Stepan Company
Apr 28, 2026, 06:30 ET Zentiva legt Berufung gegen EU-Urteil zur EU-Kommunalabwasserrichtline ein
März 2025 erhobenen Nichtigkeitsklage zu ermöglichen. Mit dieser Nichtigkeitsklage wendet sich Zentiva gegen die Artikel 9 und 10 in Verbindung mit Anhang III der KARL, in denen die erweiterte Herstellerverantwortung (EPR) verankert ist, durch die mindestens 80 % der Kosten für die neue, so genannte quartäre
More news about: Zentiva Group a.s.
Apr 28, 2026, 06:30 ET Kimberly-Clark Announces First Quarter 2026 Results, Reaffirms 2026 Outlook
view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating our results. We believe that the presentation of these non-GAAP
More news about: Kimberly-Clark Corporation
Apr 28, 2026, 06:00 ET Sowell Management Launches Cache River Private Wealth to Serve Growing High-Net-Worth Market
Advisor Partnership Program (APP) focused on growth and succession designed to support long-term business development and continuity.Rob Emrich III will serve as Chief Growth Officer for Cache River PW and will be primarily responsible for attracting experienced advisors serving high-net-worth clients
More news about: Sowell Management
Apr 28, 2026, 06:00 ET Hyperscale Data Announces $53.1 Million in Bitcoin Holdings
"The Company continues to maintain its long-term belief in Bitcoin as a core asset of its balance sheet," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "Over the past few weeks, we have taken advantage of the current price of Bitcoin to make open market
More news about: Hyperscale Data Inc.
Apr 28, 2026, 06:00 ET Nokia, Blaize, and Datacomm Diangraha Unite to Deliver Hybrid AI Inference Across Indonesia and Southeast Asia
foreign business, market, financial, political and legal conditions; (ii) the ability to maintain compliance with stock exchange listing standards; (iii) failure to realize the benefits of the business combination of Blaize and BurTech Acquisition Corp., which may be affected by, among other things, competition,
More news about: Blaize Inc.